The Significance of the Data Exclusivity and Its Impact on Generic Drugs
Overview
Research
Identity
Additional Document Info
View All
Overview
abstract
The following is a law review interview with Professor Srividhya Ragavan on the issues in interpretation of data exclusivity provisions under the TRIPS Agreement, and the impact of data exclusivity on generic drugs.